Universe Pharmaceuticals News

Universe Pharmaceuticals | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)

May 15 04:10

Universe Pharmaceuticals | F-1: Registration statement for securities of certain foreign private issuers

Apr 25 05:15

Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Feb 7 21:01

Universe Pharmaceuticals | 20-F: Registration statement / Annual report / Transition report

Jan 31 01:08

Universe Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

Sep 1, 2023 04:10

Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Aug 17, 2023 04:10

Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Aug 4, 2023 20:30

Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jul 28, 2023 04:05

Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jul 6, 2023 04:30

Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

May 25, 2023 04:21

Universe Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

May 6, 2023 04:15

Universe Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pura Vida Investments, LLC(0%),Efrem Kamen(0%)

Feb 15, 2023 03:14

Universe Pharmaceuticals: FY2022 Annual Report

20-F | Universe Pharmaceuticals INC (0001809616) (Filer)

Feb 11, 2023 05:56

Universe Pharmaceuticals | NT 20-F: Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F

Jan 31, 2023 05:15

Universe Pharmaceuticals | EFFECT: Others

Nov 16, 2022 13:15

Universe Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

Nov 14, 2022 21:02

Universe Pharmaceuticals | F-3: Registration statement for specified transactions by certain foreign private issuers

Oct 28, 2022 04:10

Universe Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

Sep 28, 2022 20:00

Universe Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

Aug 30, 2022 04:10

Universe Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

Aug 17, 2022 04:15